Loading
AAKP and Veterans Health Administration Align to Improve Veteran Lives
By American Association of Kidney Patients
WASHINGTON, Aug. 10, 2023 /PRNewswire/ — The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, announced their new partnership with the U.S Department of Veterans Affairs (VA). The formal collaboration aims to improve health outcomes and enhance the overall quality of life for Veterans with kidney diseases and is facilitated under the Veterans Health Administration’s (VHA) National Center for Healthcare Advancement and Partnerships (HAP). AAKP has extensive Veteran and Veteran family representation among its Board of Directors, National Patient Ambassadors, and grassroots membership.
AAKP is a strong advocate for greater patient care choice, patient-centered medicine, and accelerated innovations in kidney disease prevention, diagnostics, and treatments – including expanded access to kidney transplantation and new artificial implantable and wearable organs. Read the complete press release from AAKP.
Loading
Loading
September 21, 2022
@
8:00 am
–
September 23, 2022
@
5:00 pm
Each year, AAKP hosts a timely and interactive virtual meeting featuring a diverse line-up of speakers crossing all sectors of the kidney community including the top influencers in kidney care from Federal government, medical professionals, academia, private industry and non-profit professional organizations in the kidney community; along with a virtual exhibit hall which will allow participates to engage with various kidney-related companies/organizations.
All 2022 AAKP events will be held virtually to ensure the safety of all participants.
Location
Online
Loading
Loading
June 30, 2022
@
8:00 am
–
5:00 pm
The 5th Annual Policy Summit will continue to bring together key influencers from across all sectors of the policy spectrum: patients, healthcare professionals, researchers, industry, and the federal government. The focus for 2022 will be to highlight innovation in kidney biologics and diagnostics and devices, as well as examine the expanding impact of kidney disease in America and the accelerating need for policies that honor full consumer choice in treatment and smarter policies to better align both regulatory and payment decisions.
All 2022 AAKP events will be held virtually to ensure the safety of all participants.
Loading
Loading
“The American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient organization in the nation, today thanked kidney patient volunteers, their families, and kidney community allies for exercising their influence through voter registration and engagement as self-identified Kidney Voters™ through AAKP’s I Am A Kidney Voter initiative (#KIDNEYVOTER and #IAmAKidneyVoter) in the 2020 election”
“In 2018, AAKP developed and launched the first non-partisan kidney community voter education, registration, and turnout drive that had ever been attempted. In 2019, AAKP launched The Decade of the Kidney™ upon the signing of the White House Executive Order onAdvancing American Kidney Health Initiative. This strategic effort organizes kidney patient consumers nationally and globally to further drive policies that prevent kidney injury and disease, and support greater patient care choice, innovation, and timely access to care and new treatment options. Based on the grassroots tactics and online technologies refined by AAKP in 2018 and 2019, the I Am A Kidney Voter initiative has expanded rapidly to include all sectors of the kidney community, including medical professionals such as nephrologists and transplant surgeons, researchers, and workers across the medical industry and policy-influencers. AAKP estimates that their expanded platforms will engage close to 500,000 Kidney Voters™ by the 2022 election cycle while expanding kidney patient consumer demand for full immunosuppressive drug coverage for transplanted kidneys, new diagnostics to detect kidney disease far in advance of current standards, new biologics and precision medicine to treat and slow kidney disease progression, as well as bioengineered and artificial wearable and implantable kidneys to ease transplant waiting times.”
Read the full press release by AAKP, here.
Loading
Add to Google Calendar 